Autobio Diagnostics Co Ltd
SSE:603658
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
CN |
Autobio Diagnostics Co Ltd
SSE:603658
|
27.9B CNY | 21.5 | ||
CH |
Alcon AG
SIX:ALC
|
40.6B CHF | 43.2 | ||
JP |
Hoya Corp
TSE:7741
|
6.7T JPY | 40 | ||
DK |
Coloplast A/S
CSE:COLO B
|
189B DKK | 38.1 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19.2B USD | 41.6 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 55.3 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58B CNY | 33.6 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 50.4 | ||
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.4B CHF | 68.7 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.7B USD | -60.5 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.8T KRW | -56.8 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.